{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:39:29Z","timestamp":1793410769812,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005878","name":"Terveyden Tutkimuksen Toimikunta","doi-asserted-by":"publisher","award":["323706"],"award-info":[{"award-number":["323706"]}],"id":[{"id":"10.13039\/501100005878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010676","name":"H2020 Societal Challenges","doi-asserted-by":"publisher","award":["825762"],"award-info":[{"award-number":["825762"]}],"id":[{"id":"10.13039\/100010676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6"],"award-info":[{"award-number":["Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6"]}],"id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007083","name":"Orionin Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["Orionin Tutkimuss\u00e4\u00e4ti\u00f6"],"award-info":[{"award-number":["Orionin Tutkimuss\u00e4\u00e4ti\u00f6"]}],"id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["101126602"],"award-info":[{"award-number":["101126602"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00204-025-04280-0","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:14:20Z","timestamp":1768421660000},"page":"1443-1463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Atorvastatin regulates hepatic transcriptome PXR dependently but distinct from pregnenolone 16\u03b1-carbonitrile and does not induce PXR-mediated liver steatosis"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3850-5488","authenticated-orcid":false,"given":"Heba","family":"Nabil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0805-1040","authenticated-orcid":false,"given":"Mahmoud-Sobhy","family":"Elkhwanky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2081-6217","authenticated-orcid":false,"given":"Mohamed","family":"Hassanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9471-7026","authenticated-orcid":false,"given":"Einari A.","family":"Niskanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3033-9000","authenticated-orcid":false,"given":"Raghavendra","family":"Mysore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2373-0578","authenticated-orcid":false,"given":"Jorma J.","family":"Palvimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0327-3496","authenticated-orcid":false,"given":"Outi","family":"Kummu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5048-4363","authenticated-orcid":false,"given":"Jukka","family":"Hakkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"4280_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/S41569-018-0098-5","volume":"15","author":"BB Adhyaru","year":"2018","unstructured":"Adhyaru BB, Jacobson TA (2018) Safety and efficacy of statin therapy. Nat Rev Cardiol 15:757\u2013769. https:\/\/doi.org\/10.1038\/S41569-018-0098-5","journal-title":"Nat Rev Cardiol"},{"key":"4280_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-019-45839-Z","author":"HM Amemiya","year":"2019","unstructured":"Amemiya HM, Kundaje A, Boyle AP (2019) The ENCODE blacklist: identification of problematic regions of the genome. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-019-45839-Z","journal-title":"Sci Rep"},{"key":"4280_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153767","author":"SA Barretto","year":"2019","unstructured":"Barretto SA, Lasserre F, Fougerat A et al (2019) Molecular Sciences Gene Expression Profiling Reveals that PXR Activation Inhibits Hepatic PPAR\u03b1 Activity and Decreases FGF21 Secretion in Male C57Bl. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20153767","journal-title":"Int J Mol Sci"},{"key":"4280_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrendo.2015.194","volume":"12","author":"DJ Betteridge","year":"2016","unstructured":"Betteridge DJ, Carmena R (2016) The diabetogenic action of statins - mechanisms and clinical implications. Nat Rev Endocrinol 12:99\u2013110. https:\/\/doi.org\/10.1038\/nrendo.2015.194","journal-title":"Nat Rev Endocrinol"},{"key":"4280_CR6","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s00204-014-1348-x","volume":"89","author":"A Bitter","year":"2015","unstructured":"Bitter A, R\u00fcmmele P, Klein K et al (2015) Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms. Arch Toxicol 89:2089\u20132103. https:\/\/doi.org\/10.1007\/s00204-014-1348-x","journal-title":"Arch Toxicol"},{"key":"4280_CR7","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1124\/DMD.113.051698","volume":"41","author":"L Bj\u00f6rkhem-Bergman","year":"2013","unstructured":"Bj\u00f6rkhem-Bergman L, Bergstr\u00f6m H, Johansson M et al (2013) Atorvastatin treatment induces uptake and efflux transporters in human liver. Drug Metab Dispos 41:1610\u20131615. https:\/\/doi.org\/10.1124\/DMD.113.051698","journal-title":"Drug Metab Dispos"},{"key":"4280_CR8","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1101\/GAD.12.20.3195","volume":"12","author":"B Blumberg","year":"1998","unstructured":"Blumberg B, Sabbagh W, Juguilon H et al (1998) SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 12:3195\u20133205. https:\/\/doi.org\/10.1101\/GAD.12.20.3195","journal-title":"Genes Dev"},{"key":"4280_CR9","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/BIOINFORMATICS\/BTU170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics 30:2114\u20132120. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTU170","journal-title":"Bioinformatics"},{"key":"4280_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/J.CMET.2011.02.004","volume":"13","author":"GT Bommer","year":"2011","unstructured":"Bommer GT, MacDougald OA (2011) Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a locus. Cell Metab 13:241\u2013247. https:\/\/doi.org\/10.1016\/J.CMET.2011.02.004","journal-title":"Cell Metab"},{"key":"4280_CR11","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/NMETH.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro JD, Giresi PG, Zaba LC et al (2013) Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods 10:1213\u20131218. https:\/\/doi.org\/10.1038\/NMETH.2688","journal-title":"Nat Methods"},{"key":"4280_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/0471142727.MB2129S109","author":"JD Buenrostro","year":"2015","unstructured":"Buenrostro JD, Wu B, Chang HY, Greenleaf WJ (2015) ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr Protoc Mol Biol. https:\/\/doi.org\/10.1002\/0471142727.MB2129S109","journal-title":"Curr Protoc Mol Biol"},{"key":"4280_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/S40168-017-0312-4","volume":"5","author":"JA Caparr\u00f3s-Mart\u00edn","year":"2017","unstructured":"Caparr\u00f3s-Mart\u00edn JA, Lareu RR, Ramsay JP et al (2017) Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism. Microbiome 5:95. https:\/\/doi.org\/10.1186\/S40168-017-0312-4","journal-title":"Microbiome"},{"key":"4280_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11883-019-0780-z","volume":"21","author":"R Carmena","year":"2019","unstructured":"Carmena R, Betteridge DJ (2019) Diabetogenic action of statins: mechanisms. Curr Atheroscler Rep 21:23. https:\/\/doi.org\/10.1007\/s11883-019-0780-z","journal-title":"Curr Atheroscler Rep"},{"key":"4280_CR15","doi-asserted-by":"publisher","first-page":"7943","DOI":"10.1093\/NAR\/GKQ654","volume":"38","author":"JY Cui","year":"2010","unstructured":"Cui JY, Gunewardena SS, Rockwell CE, Klaassen CD (2010) ChIPing the cistrome of PXR in mouse liver. Nucleic Acids Res 38:7943\u20137963. https:\/\/doi.org\/10.1093\/NAR\/GKQ654","journal-title":"Nucleic Acids Res"},{"key":"4280_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/BIOINFORMATICS\/BTS635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTS635","journal-title":"Bioinformatics"},{"key":"4280_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/J.CLINRE.2021.101816","author":"K Fatima","year":"2022","unstructured":"Fatima K, Moeed A, Waqar E et al (2022) Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. https:\/\/doi.org\/10.1016\/J.CLINRE.2021.101816","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"4280_CR18","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1124\/DMD.110.033886","volume":"38","author":"DM Feidt","year":"2010","unstructured":"Feidt DM, Klein K, Hofmann U et al (2010) Profiling induction of cytochrome p450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytes. Drug Metab Dispos 38:1589\u20131597. https:\/\/doi.org\/10.1124\/DMD.110.033886","journal-title":"Drug Metab Dispos"},{"key":"4280_CR19","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jhep.2018.12.038","volume":"70","author":"T Gwag","year":"2019","unstructured":"Gwag T, Meng Z, Sui Y et al (2019) Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis. J Hepatol 70:930\u2013940. https:\/\/doi.org\/10.1016\/j.jhep.2018.12.038","journal-title":"J Hepatol"},{"key":"4280_CR20","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.bbagrm.2016.03.012","volume":"1859","author":"J Hakkola","year":"2016","unstructured":"Hakkola J, Rys\u00e4 J, Hukkanen J (2016) Regulation of hepatic energy metabolism by the nuclear receptor PXR. Biochim Biophys Acta 1859:1072\u20131082. https:\/\/doi.org\/10.1016\/j.bbagrm.2016.03.012","journal-title":"Biochim Biophys Acta"},{"key":"4280_CR21","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1007\/s00204-020-02936-7","volume":"94","author":"J Hakkola","year":"2020","unstructured":"Hakkola J, Hukkanen J, Turpeinen M, Pelkonen O (2020) Inhibition and induction of CYP enzymes in humans: an update. Arch Toxicol 94:3671\u20133722. https:\/\/doi.org\/10.1007\/s00204-020-02936-7","journal-title":"Arch Toxicol"},{"key":"4280_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bcp.2018.01.001","volume":"148","author":"F Hassani-Nezhad-Gashti","year":"2018","unstructured":"Hassani-Nezhad-Gashti F, Rys\u00e4 J, Kummu O et al (2018) Activation of nuclear receptor PXR impairs glucose tolerance and dysregulates GLUT2 expression and subcellular localization in liver. Biochem Pharmacol 148:253\u2013264. https:\/\/doi.org\/10.1016\/j.bcp.2018.01.001","journal-title":"Biochem Pharmacol"},{"key":"4280_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N et al (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38:576\u2013589. https:\/\/doi.org\/10.1016\/j.molcel.2010.05.004","journal-title":"Mol Cell"},{"key":"4280_CR24","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/NAR\/GKJ144","volume":"34","author":"AS Hinrichs","year":"2006","unstructured":"Hinrichs AS, Karolchik D, Baertsch R et al (2006) The UCSC Genome Browser Database: update 2006. Nucleic Acids Res 34:D590. https:\/\/doi.org\/10.1093\/NAR\/GKJ144","journal-title":"Nucleic Acids Res"},{"key":"4280_CR25","doi-asserted-by":"publisher","unstructured":"Hoffart E, Ghebreghiorghis L, Nussler A et al (2011) Effects of Atorvastatin metabolites on induction of drug-metabolizing enzymes and membrane transporters through human pregnane X receptor BACKGROUND AND PURPOSE. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01665.x","DOI":"10.1111\/j.1476-5381.2011.01665.x"},{"key":"4280_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3109\/00498254.2011.569773","volume":"41","author":"K Howe","year":"2011","unstructured":"Howe K, Sanat F, Thumser AE et al (2011) The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes. Xenobiotica 41:519\u2013529. https:\/\/doi.org\/10.3109\/00498254.2011.569773","journal-title":"Xenobiotica"},{"key":"4280_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/BCP.12701","volume":"80","author":"J Hukkanen","year":"2015","unstructured":"Hukkanen J, Puurunen J, Hy\u00f6tyl\u00e4inen T et al (2015) The effect of atorvastatin treatment on serum oxysterol concentrations and cytochrome P450 3A4 activity. Br J Clin Pharmacol 80:473\u2013479. https:\/\/doi.org\/10.1111\/BCP.12701","journal-title":"Br J Clin Pharmacol"},{"key":"4280_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4254\/WJH.V14.I1.168","volume":"14","author":"SM Jeyakumar","year":"2022","unstructured":"Jeyakumar SM, Vajreswari A (2022) Stearoyl-CoA desaturase 1: a potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence. World J Hepatol 14:168\u2013179. https:\/\/doi.org\/10.4254\/WJH.V14.I1.168","journal-title":"World J Hepatol"},{"key":"4280_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-12-507","author":"MA Kallio","year":"2011","unstructured":"Kallio MA, Tuimala JT, Hupponen T et al (2011) Chipster: user-friendly analysis software for microarray and other high-throughput data. BMC Genomics. https:\/\/doi.org\/10.1186\/1471-2164-12-507","journal-title":"BMC Genomics"},{"key":"4280_CR30","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/bph.15433","volume":"178","author":"M Karpale","year":"2021","unstructured":"Karpale M, K\u00e4r\u00e4j\u00e4m\u00e4ki AJ, Kummu O et al (2021) Activation of pregnane X receptor induces atherogenic lipids and PCSK9 by a SREBP2-mediated mechanism. Br J Pharmacol 178:2461\u20132481. https:\/\/doi.org\/10.1111\/bph.15433","journal-title":"Br J Pharmacol"},{"key":"4280_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLMET.2023.101779","author":"M Karpale","year":"2023","unstructured":"Karpale M, Kummu O, K\u00e4rkk\u00e4inen O et al (2023) Pregnane X receptor activation remodels glucose metabolism to promote NAFLD development in obese mice. Mol Metab. https:\/\/doi.org\/10.1016\/J.MOLMET.2023.101779","journal-title":"Mol Metab"},{"key":"4280_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.tox.2010.11.008","volume":"280","author":"H Kojima","year":"2011","unstructured":"Kojima H, Sata F, Takeuchi S et al (2011) Comparative study of human and mouse pregnane X receptor agonistic activity in 200 pesticides using in vitro reporter gene assays. Toxicology 280:77\u201387. https:\/\/doi.org\/10.1016\/j.tox.2010.11.008","journal-title":"Toxicology"},{"key":"4280_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer A, Green J, Pollard JJ, Tugendreich S (2014) Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30:523\u2013530. https:\/\/doi.org\/10.1093\/bioinformatics\/btt703","journal-title":"Bioinformatics"},{"key":"4280_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102615","author":"A Kropotov","year":"2022","unstructured":"Kropotov A, Kulikova V, Solovjeva L et al (2022) Purine nucleoside phosphorylase controls nicotinamide riboside metabolism in mammalian cells. J Biol Chem. https:\/\/doi.org\/10.1016\/j.jbc.2022.102615","journal-title":"J Biol Chem"},{"key":"4280_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1021\/MP700121U","volume":"5","author":"JH Lee","year":"2008","unstructured":"Lee JH, Zhou J, Xie W (2008) PXR and LXR in hepatic steatosis: a new dog and an old dog with new tricks. Mol Pharm 5:60\u201366. https:\/\/doi.org\/10.1021\/MP700121U","journal-title":"Mol Pharm"},{"key":"4280_CR36","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/cbf.3495","volume":"38","author":"T Li","year":"2020","unstructured":"Li T, Huang X, Yue Z et al (2020) Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease. Cell Biochem Funct 38:839\u2013846. https:\/\/doi.org\/10.1002\/cbf.3495","journal-title":"Cell Biochem Funct"},{"key":"4280_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bcp.2015.11.023","volume":"100","author":"Z Ling","year":"2016","unstructured":"Ling Z, Shu N, Xu P et al (2016) Involvement of pregnane X receptor in the impaired glucose utilization induced by atorvastatin in hepatocytes. Biochem Pharmacol 100:98\u2013111. https:\/\/doi.org\/10.1016\/j.bcp.2015.11.023","journal-title":"Biochem Pharmacol"},{"key":"4280_CR38","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1016\/j.apsb.2021.09.031","volume":"12","author":"P Liu","year":"2021","unstructured":"Liu P, Jiang L, Kong W et al (2021) PXR activation impairs hepatic glucose metabolism partly via inhibiting the HNF4\u03b1\u2013GLUT2 pathway. Acta Pharm Sin B 12:2391\u20132405. https:\/\/doi.org\/10.1016\/j.apsb.2021.09.031","journal-title":"Acta Pharm Sin B"},{"key":"4280_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/S13059-014-0550-8","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. https:\/\/doi.org\/10.1186\/S13059-014-0550-8","journal-title":"Genome Biol"},{"key":"4280_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109174","author":"X Lu","year":"2024","unstructured":"Lu X, Yang R, Chen Y, Chen D (2024) NAD metabolic therapy in metabolic dysfunction-associated steatotic liver disease: possible roles of gut microbiota. iScience. https:\/\/doi.org\/10.1016\/j.isci.2024.109174","journal-title":"iScience"},{"key":"4280_CR41","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/BIOINFORMATICS\/BTS277","volume":"28","author":"S Neph","year":"2012","unstructured":"Neph S, Kuehn MS, Reynolds AP et al (2012) BEDOPS: High-performance genomic feature operations. Bioinformatics 28:1919\u20131920. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTS277","journal-title":"Bioinformatics"},{"key":"4280_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/J.JHEPR.2021.100346","author":"L Parlati","year":"2021","unstructured":"Parlati L, R\u00e9gnier M, Guillou H, Postic C (2021) New targets for NAFLD. JHEP Rep. https:\/\/doi.org\/10.1016\/J.JHEPR.2021.100346","journal-title":"JHEP Rep"},{"key":"4280_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/BCP.14943","volume":"88","author":"D Pastori","year":"2022","unstructured":"Pastori D, Pani A, Di Rocco A et al (2022) Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis. Br J Clin Pharmacol 88:441\u2013451. https:\/\/doi.org\/10.1111\/BCP.14943","journal-title":"Br J Clin Pharmacol"},{"key":"4280_CR3","doi-asserted-by":"crossref","unstructured":"Poli A (2007) Atorvastatin pharmacological characteristics and lipid-lowering effects by inhibiting 3-hydroxy-3-methylglutaryl coenzyme-A. HMG-CoA) reduc","DOI":"10.2165\/00003495-200767001-00002"},{"key":"4280_CR44","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/BIOINFORMATICS\/BTQ033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM (2010) Bedtools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26:841\u2013842. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTQ033","journal-title":"Bioinformatics"},{"key":"4280_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/NCOMMS13103","author":"J Ratajczak","year":"2016","unstructured":"Ratajczak J, Joffraud M, Trammell SAJ et al (2016) NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat Commun. https:\/\/doi.org\/10.1038\/NCOMMS13103","journal-title":"Nat Commun"},{"key":"4280_CR46","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/clpt.2013.48","volume":"93","author":"J Rys\u00e4","year":"2013","unstructured":"Rys\u00e4 J, Buler M, Savolainen MJ et al (2013) Pregnane X receptor agonists impair postprandial glucose tolerance. Clin Pharmacol Ther 93:556\u2013563. https:\/\/doi.org\/10.1038\/clpt.2013.48","journal-title":"Clin Pharmacol Ther"},{"key":"4280_CR47","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2017.91","volume":"13","author":"H Shimano","year":"2017","unstructured":"Shimano H, Sato R (2017) SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat Rev Endocrinol 13:710\u2013730. https:\/\/doi.org\/10.1038\/nrendo.2017.91","journal-title":"Nat Rev Endocrinol"},{"key":"4280_CR48","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1074\/jbc.M113.494575","volume":"289","author":"K Spruiell","year":"2014","unstructured":"Spruiell K, Richardson RM, Cullen JM et al (2014) Role of pregnane X receptor in obesity and glucose homeostasis in male mice. J Biol Chem 289:3244\u20133261. https:\/\/doi.org\/10.1074\/jbc.M113.494575","journal-title":"J Biol Chem"},{"key":"4280_CR50","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1210\/me.2014-1355","volume":"29","author":"Y Sui","year":"2015","unstructured":"Sui Y, Helsley RN, Park S-H et al (2015) Intestinal pregnane X receptor links xenobiotic exposure and hypercholesterolemia. Mol Endocrinol 29:765\u2013776. https:\/\/doi.org\/10.1210\/me.2014-1355","journal-title":"Mol Endocrinol"},{"key":"4280_CR49","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1124\/JPET.113.208595","volume":"347","author":"E Van De Steeg","year":"2013","unstructured":"Van De Steeg E, Kleemann R, Jansen HT et al (2013) Combined analysis of Pharmacokinetic and efficacy data of preclinical studies with Statins markedly improves translation of drug efficacy to human trials. J Pharmacol Exp Ther 347:635\u2013644. https:\/\/doi.org\/10.1124\/JPET.113.208595","journal-title":"J Pharmacol Exp Ther"},{"key":"4280_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/S44321-024-00130-1","author":"C Van Dender","year":"2024","unstructured":"Van Dender C, Timmermans S, Paakinaho V et al (2024) A critical role for HNF4\u03b1 in polymicrobial sepsis-associated metabolic reprogramming and death. EMBO Mol Med. https:\/\/doi.org\/10.1038\/S44321-024-00130-1","journal-title":"EMBO Mol Med"},{"key":"4280_CR52","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/SCIENCE.AAC4854","volume":"350","author":"E Verdin","year":"2015","unstructured":"Verdin E (2015) NAD\u2009+\u2009in aging, metabolism, and neurodegeneration. Sci (1979) 350:1208\u20131213. https:\/\/doi.org\/10.1126\/SCIENCE.AAC4854","journal-title":"Sci (1979)"},{"key":"4280_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0067959","author":"J Zhang","year":"2013","unstructured":"Zhang J, Wei Y, Hu B et al (2013) Activation of human stearoyl-coenzyme A desaturase 1 contributes to the lipogenic effect of PXR in HepG2 cells. PLoS One. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0067959","journal-title":"PLoS One"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04280-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04280-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04280-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:38:16Z","timestamp":1775036296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04280-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4280"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04280-0","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}